R e s u l t s : P r oviders enforced a va riety of restrictions known to impede clients' access to services. Concerns about client safety and morals were the most often cited rationales for restricting services according to age and parity. Many providers were especially concerned that cont ra c e p t i ves might cause future fe rtility probl e m s, and used minimum age or parity requirements to ensure that only women of proven fe rtility could obtain contra c e p t i ve s. A number of prov i d e r s apparently believed in particular that injectable contra c e p t i ves cause permanent infe rt i l i t y. Prov i d e r s also cited health concerns as the reason for enforcing strict resupply and revisit schedules, as well as for routinely conducting laboratory tests.
Context
In 1969, Ghana became one of the first African countries to adopt a population p o l i c y. Acceptance of family planning was s l o w, however, and 20 years later, in 1988, the prevalence of modern contraceptive use had reached only 5%. Between 1988 and 1998 , though, the use of modern contraceptive methods nearly tripled, fro m 5% to 13%. At the same time, the total fertility rate dropped from 6.4 to 4.5 lifetime births per woman. 3 To improve quality of care and clients'access to family planning and other re p roductive health services, Ghana recently developed and disseminated National Reproductive Health Service Protocols (with technical assistance from INTRAH a n d P R I M E ) . 4 A few years before, Ghana also had formulated new service delivery policies and standards. All of those guidelinesuniform rules to which all family planning service delivery points should adhere -a re designed to remove medical barriers and replace diff e rences between clinical practices with uniform, quality services. Written ru l e s may also protect providers, many of whom fear being blamed by dissatisfied clients or their partners.
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Why Do Family Planning Providers Restrict Access to Services? An Examination in Ghana
By John Stanback and K.A. Twum-Baah W hat impedes providers fro m adopting a client orientation? Why do medical barriers persist? How can training be made more e ffective? In short: What determines family planning provider practices? The answers remain elusive, but in recent years re s e a rchers have begun to shine a light in what has been called the "black box" 1 o f family planning service delivery. 2 A variety of tools-in-depth interviews, simulated client studies, and observationshave been used to explain not just "what" p roviders do, but also "why" they do it. A better understanding of pro v i d e r behavior is an important key to designing training, supervision and logistic systems that maximize access and quality of care.
Recent attempts at explaining pro v i d e r behavior have produced illuminating findings, but have only hinted at the constellation of factors that influence service delivery. In this article, we report data from a study in Ghana designed to find out from providers themselves why they impose certain restrictions on clients or engage in medically unnecessary practices.
Methods
Situation analyses conducted in Ghana in 1993 and 1996 have proven helpful in identifying weaknesses in Ghana's family planning system, by revealing a variety of barriers to access to family planning services.
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H o w e v e r, because questions about w h y certain practices are performed are not included in the standard situation analysis m e t h o d o l o g y, we conducted a follow-up study in 1994 to learn more about pro v i d e r rationales for restrictive practices.
To maximize the amount of useful data per site, we used a "negative deviance" s t r a t e g y, targeting the providers most likely to impose restrictive barriers to services. Using data from the 1993 situation analysis, we created a "barriers to access" index in 1994 for each of the 719 active family planning providers interviewed in that s t u d y. The index was simple: A point was added to a pro v i d e r's score for each reported medical or social restriction to services, including parity re q u i rements, minimum and maximum age limits, laboratory testing re q u i rements, marriage and spousal consent re q u i rements, and others.
Forty-six service delivery points t h rough-out Ghana were chosen as study sites on the basis of high scores fro m providers at these sites. Three interviewers visited the 46 sites late in 1994 and conducted interviews lasting 1-3 hours. All available providers were interviewed at each site, leading to a final sample of 97 providers.
In each interview, the interviewer first asked the providers a series of simple questions about their clinical practices. A response protocol was then used to pro b e any responses to the original questions indicating service practices that might be c o n s t rued as access barriers. For example, p roviders who said they imposed minimum parity re q u i rements for pill clients w e re asked their reasons for doing so. F i n a l l y, the interviewer reviewed the site's daily register and examined a sample of as they do not ordinarily provide family planning services at Ghana's public-sector and nongovernmental service delivery points.)
All 46 sites offered combined oral contraceptives, injectables, condoms and spermicides. Forty-four sites off e red pro gestin-only oral contraceptives, 36 IUDs and five (all hospitals) female sterilization services.
Service Restrictions
•Marriage and spousal consent re q u i re m e n t s . In clinics visited in both the 1993 and the 1996 situation analyses, about 40% of p roviders in both surveys reported that marriage was a pre requisite for a client to be off e red at least one nonpermanent m e t h o d .
6 Spousal consent re q u i re m e n t s were even more common.
P roviders in our sample of "high barrier" facilities gave a variety of re a s o n s for enforcing marriage re q u i rements. The most common, accounting for one-fourth to one-third of responses (depending on method), was simply that for moral re asons single women should not be allowed to use family planning. Other pro v i d e r s said explicitly that such restrictions discourage indiscriminate sex among unclient re c o rds, to validate certain questionnaire responses. For example, the interviewers noted the age and parity range of clients and whether re c o rds indicated routine re q u i rements for laboratory tests, pelvic examinations of hormonal method clients or written spousal consent.
This sample was not re p resentative of all family planning providers in Ghana: We deliberately chose facilities where client faced multiple barriers to access. H o w e v e r, we believed that such a sample would be both a cost-effective and rich s o u rce of data on commonly reported re asons for enforcing such barriers.
Results

Basic Indicators
The 46 study sites consisted of nine hospitals, 12 health centers, 10 health posts, seven maternity homes, four maternal and child health or family planning clinics, two Planned Parenthood Association of Ghana clinics, a private clinic and a quasi-g o vernmental clinic. They were located in seven of Ghana's 10 regions.
Among the 97 personnel surveyed were 52 auxiliary nurses, 42 professional nursemidwives, two extension workers and one v o l u n t e e r. (No doctors were interviewed, married women.
Other rationales for the marriage req u i rement were specific to various methods. For example, eight IUD pro v i d e r s said they used the marriage restriction to s c reen out potentially promiscuous IUD clients, presumably to reduce the risk of postinsertion infections. Three pro v i d e r s stated that hormonal methods work continuously and thus are unnecessary for unmarried clients, who may not regularly have sex. One provider worried that unmarried clients might use oral contraceptives to induce abortion.
The most common reasons for spousal consent re q u i rements were variations on the idea that family planning is a decision for both partners or that the husband might oppose family planning or the wife's choice of method (Table 1) . Other p roviders worried about being accused by spouses of providing contraceptives, especially if their use led to side effects, infertility or pro m i s c u i t y. Some pre d i c t e d that without spousal consent rules, husbands would accuse wives of infidelity, leading to "punishment," "divorce" and even "fatal consequences." Clients were m o re likely to face both marriage req u i rements and spousal consent re q u i rements at government health centers, at health posts, and at maternal and child health and family planning clinics than they were at hospitals and maternity homes (not shown).
•Age re s t r i c t i o n s . M o re than half of p roviders in both 1993 and 1996 said they e n f o rced minimum and maximum age req u i rements for various methods. Such restrictions were particularly stringent for injectables. In our purposive sample of service providers, the mean m i n i m u m a g e for prescription of this method was more than 30 years.
When asked their reasons for enforc i n g minimum age re q u i rements, providers at the "high barrier" facilities most commonly responded with some variation on the notion that the minimum was the age at which women were old enough to marry and have children (Table 1) . Some e x p ressed the negative version of this idea-i.e., that family planning should not be allowed for anyone younger than a certain age, or that a minimum age discourages pro m i s c u i t y, or that women younger than this age are not mature enough for family planning. (Most providers did not differentiate between physical and mental maturity.)
Other reasons given for minimum age limits re f e r red to specific methods and reflected providers' concerns for clients' Note: na=not applicable.
for at least one nonpermanent method. Int e re s t i n g l y, parity re q u i rements for injectables-sometimes for three, four or even five childre n -w e re uniformly more strict than those for IUDs. Preeminent among the rationales for a minimum parity limit was the belief that hormonal methods, particularly injectables, delay fertility or cause infertility. Among the 80 providers at "high barrier" sites who gave reasons for enforcing parity limits for injectables, nearly all (94%) used some variation of this reason (Table  1) . Responses to other questions also indicated that many providers believe injectables cause permanent infertility. One provider said she would not recommend injectables to breastfeeding women because "the client may want to have m o re children." Another said that "injectables are too strong for the ovaries and d e s t roy them." Dozens of others said or implied that various service re s t r i c t i o n s p rotected the client (or helped the p rovider escape blame) from infertility caused by injectables.
Delayed fertility or infertility was also the most common reason (thre e -q u a r t e r s of stated reasons) for parity limits on the pill (both for progestin-only and for combined formulations). One-third of p roviders also re q u i red that IUD clients have at least one child, and sometimes up to five children. One-third of IUD providers who reported imposing parity restrictions cited possible infertility, while another third mentioned tight cervixes as rationales. Three of the 33 said that the parity re q u i rement helped them escape blame if the IUD left the woman infertile.
The following comments illustrate a few of the seemingly illogical re a s o n s given for IUD parity re q u i rements. One was that "the device causes symptoms of p regnancy such as nausea, so this req u i rement ensures that such symptoms will not be a new thing to the client." Another provider observed that "the IUD nourishes the uterus, so after removal the client can become pregnant."
Other Service Practices
•Laboratory testing and blood pre s s u re . In the 1993 situation analysis, more than half of p roviders surveyed indicated that they routinely re q u i red laboratory tests of blood or urine before prescribing certain methods. Some re s e a rchers have speculated, however, that the prevalence of this barrier may be exaggerated, due to the way the question was posed to pro v i d e r s . Yet in our visits to the "high barrier" sites health. For example, providers seemed to re g a rd injectable contraceptives as particularly risky, and they rationalized age restrictions on this method by citing concerns about infertility or a delay in the return to fertility.
A few providers explained that minimum age restrictions (which, in effect, are also minimum parity restrictions) verify clients' fertility or help them avoid blame from clients who might later prove infertile. Three providers explained that they set age 35 as a minimum for injectable use by saying that "at age 35 clients have child ren and are nearing menopause, so if they become infertile from injectables, it won't worry them."
Concern for clients' health was also reflected in other rationales. For example, 12 providers claimed that age re s t r i c t i o n s w e re necessary for pills and injectables because young women faced a higher risk of complications from hormonal methods. Two others suggested that when women a re younger than 18 or 20, their re p roductive organs are too immature for use of hormonal contraceptives.
A few rationales off e red were notable for being incorrect or illogical. For example, two providers said that minimum age limits were intended to forestall teenage p regnancies. One stated that pro ge s t i n-only pills inhibit lactation; another claimed that combined pills, once terminated, increase fertility. Finally, thre e p roviders explained their minimum age limit for injectables by saying that the method is dangerous for women younger than 35.
P roviders in our sample enforcing maximum age limits for their clients usually cited menopause and health concerns ( Table 1) . Half of those denying combined pills to older women (usually 35 or older) said that such pills were dangerous or that older clients run higher risks of hypertension or cardiovascular disease. Some also said that "hormonals may lead to early menopause in clients," and that "hidden diseases are exposed after age 35 and may be confused with side effects of the method." In addition, a few thought that some methods (injectables, IUDs, condoms and spermicides) were unacceptable to older clients.
•Parity re s t r i c t i o n s . Parity re q u i re m e n t s specify that women must have a minimum number of children before re c e i v i n g a method. These were among the most common eligibility barriers found in the 1993 and 1996 situation analyses; more than half of providers in both surveys claimed to enforce minimum parity ru l e s ( w h e re three-quarters of providers reported routine use of lab tests), review of m o re than 2,400 client cards revealed that such testing appeared routine in 34 of the 46 locations.
To assess providers' knowledge, interviewers asked respondents who said they routinely re q u i red such tests what their purpose was and what were acceptable results or ranges. Most demonstrated a good or adequate knowledge of the rationales for both blood and urine testing and acceptable results or ranges. When asked how they managed cases of abnormal test results, fewer than half said they would provide the method while awaiting confirmation.
As a test of knowledge, interviewers also asked providers why they measure d clients' blood pre s s u re, as well as what blood pre s s u re ranges are acceptable for hormonal methods and IUDs. All showed adequate knowledge of the reasons for taking blood pre s s u re. However, more than three-quarters gave upper limits on blood pre s s u re that were lower than those recommended in Ghana's guidelines (160/100), and might there f o re restrict access to contraception or unnecessarily reduce a client's choice of methods.
•Follow-up and re s u p p l y. Although Ghana's new re p roductive health service delivery p rotocols recommend only one follow-up visit for IUD clients in the first year (in the absence of problems), multiple scheduled revisits for IUD clients may still be a pro blem in Ghana, as in other countries. Among the 85 IUD providers in our purposive sample, 36% said they re q u i re d four or more visits during the first year of IUD use, 31% required three and 33% req u i red two or fewer. When asked the re ason for multiple IUD revisits, almost all p roviders explained that they verified that the IUD was in place, checked for complications or counseled the client about infection prevention.
We also assessed oral contraceptive supply and re s u p p l y, as Ghana's service protocols specify the number of pill cycles to be provided for new clients (three) and continuing clients (7-13). In the 1996 situation analysis, 84% of all providers said they supplied only one cycle of pills at the initial visit, and more than 80% said they routinely provided three or fewer cycles for revisiting clients who had successfully used the pill for a year or more. In our smaller sample, when asked why they provided fewer than three cycles during follow-up visits, most providers cited the need for frequent health check-ups due to health problems undetectable by clients. planning services will not prevent such behavior. Instead, it may expose them to unwanted pregnancies and sexually transmitted diseases.
•Do providers know why they perform certain clinical and laboratory practices and what anomalous results mean? Most had adequate knowledge of the reasons for measuring blood pre s s u re and conducting laboratory tests. A number, though, enforc e d low upper limits on blood pre s s u re; these might reduce clients' access to eff e c t i v e contraceptives, especially if no distinction is made between estro g e n-c o n t a i n i n g methods and progestin-only methods.
Although blood pre s s u re measurements can be useful in a clinic setting, the utility of requiring laboratory tests is questionable, especially if women who cannot a ff o rd such testing are denied services (as was reported by several providers). The most commonly re q u i red blood test, that for hemoglobin, is useful when the IUD is being prescribed, but is not indicated for combined pills, which have been shown to increase hemoglobin levels in anemic clients.
8 Ironically, in the situation analysis, the proportion of active providers requiring hemoglobin tests was greater for hormonal methods than for IUDs. This was unexpected, not only because such tests are less useful for hormonal methods, but also because IUD providers generally work in better-equipped clinics. Other common tests, such as for kidney function (albumin), urine sugar (glucose) and sickle-cell disease, are also of questionable value in this setting.
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When lab test results are abnormal, fewer than half of providers in our sample said they would provide a method while the client was treated, counseled or retested. This is unfortunate, since in the absence of other symptoms, the pro v i d e r' s first responsibility to a woman at risk of p regnancy should be to prescribe an effective contraceptive method. Further, it is possible that an abnormal test re s u l t stems from a treatable condition, a condition that could be affected more by pre gnancy than by contraceptive use, or a false-positive test result. In any case, if retests confirm a diagnosis, or if the client's condition worsens during contraceptive use, the method can always be discontinued without lasting ill effects.
Ghana Under these new protocols, laboratory testing is not mandatory for any method.
•Why do providers re q u i re IUD clients to
•Services for breastfeeding and nonmenstruating clients. When asked which methods they recommended to bre a s t f e e d i n g clients, about 90% of providers at the 46 "high barrier" sites said they re c o mmended progestin-only pills or the IUD. Fewer than half recommended injectables. To assess bias against injectable contraceptives, interviewers asked those not mentioning injectables why they did not do so. About three-quarters said injectables reduce the quantity of breast milk or interfere with lactation.
In the 1996 situation analysis, pro v i d e r s were asked how they managed nonmens t ruating clients presenting at the service location for hormonal methods. Half mentioned using pregnancy tests, but even m o re mentioned sending clients home, with or without a barrier method. Providers in our purposive sample were asked for more details on the various ways in which they ruled out pregnancy for n o n m e n s t ruating clients. Most mentioned the use of pregnancy tests. However, only a few noted any of the other means of ru ling out pregnancy specified in Ghana's guidelines, including exclusive bre a s tfeeding and client history.
Discussion
Our objective was to learn why pro v i d e r s restrict client access to family planning services in Ghana. Although this was not an in-depth study of the cultural context of providers' personal and pro f e s s i o n a l lives, we obtained some interesting results.
•Why do providers place age, parity, spousal consent, and marriage restrictions on particular methods? Restrictions based on age, p a r i t y, marital status and spousal consent are arbitrary, in the sense that most have no medical justification. However, providers in our sample appear to have imposed these restrictions with the best of intentions. Most providers seemed to feel that by doing so, they were pro t e c t i n g both the client and society. P roviders believed they were pro t e c ting their clients by denying them access to methods that caused infertility or other health problems. Ghana's new family planning standards and protocols may not address these issues explicitly enough.
A more difficult problem is that p roviders also wanted to protect their society and culture by preserving traditional values and moral strictures against sex outside of marriage. This debate is common to most cultures, but as health professionals, providers must come to understand that denying women family make so many follow-up visits? Most IUD clients at the sites in our purposive sample were asked to return for revisits thre e or more times in the first year after IUD insertion. Providers justified multiple revisits by citing the need to verify the pre sence of the IUD and to check for infection. In recent years, experts have expre s s e d concern that multiple IUD revisits are not useful or cost-effective, that they exacerbate overc rowding at some clinics and that they may discourage potential IUD acceptors.
11 Ghana's current recommendation, therefore, is that safe IUD provision need only include a one-month follow-u p visit and careful counseling of clients to return if problems occur.
•Why are oral contraceptive clients not given m o re pill packets per visit? Many pro v i d e r s seem convinced that oral contraceptive clients need frequent check-ups to avoid serious medical problems. For this re a s o n , eight in 10 providers in the most recent situation analysis gave only one pill packet at the first visit and three or fewer at subsequent visits.
1 2 Yet side effects from the pill a re almost always minor, and almost any p roblem, minor or major, can be detected by a well-counseled client for whom the pill was indicated at the initial examination.
•Why is contraception not provided to nonmenstruating new clients? Denial of services to clients who are not menstruating is a serious barrier to family planning services around the world. 1 3 We found that when p roviders were asked how they ruled out p regnancy among nonmenstru a t i n g clients, most mentioned only pre g n a n c y tests. This indicates that providers did not know about, or were uncomfortable with, other means of ruling out pre g n a n c y, such as a client history.
Conclusions
Providers in our nonrepresentative sample showed inadequate technical knowledge of the precautions against and side e ffects of modern contraceptive methods. Their goal of protecting their clients is admirable, but in exaggerating the dangers of contraceptive use, they may be doing more harm than good. Injectables are especially misunderstood. As has been noted in other African countries, 1 4 many p roviders seem to have exaggerated notions of injectable-related infertility. Furt h e r, age and parity re q u i rements for injectables are particularly burdensome, and few providers recommend injectables to breastfeeding clients.
M o re o v e r, in imposing personal values and mistrusting their clients, pro v i d e r s demonstrate a want of empathy and pro-
